238 related articles for article (PubMed ID: 26138194)
1. Intriguing possibilities and beneficial aspects of transporter-conscious drug design.
Tashima T
Bioorg Med Chem; 2015 Aug; 23(15):4119-4131. PubMed ID: 26138194
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
Pardridge WM
Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
[TBL] [Abstract][Full Text] [Related]
3. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
4. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
Chaves C; Shawahna R; Jacob A; Scherrmann JM; Declèves X
Curr Pharm Des; 2014; 20(10):1450-62. PubMed ID: 23789951
[TBL] [Abstract][Full Text] [Related]
5. Disease-Induced Modulation of Drug Transporters at the Blood-Brain Barrier Level.
Al Rihani SB; Darakjian LI; Deodhar M; Dow P; Turgeon J; Michaud V
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916769
[TBL] [Abstract][Full Text] [Related]
6. Drug transporters in drug efficacy and toxicity.
DeGorter MK; Xia CQ; Yang JJ; Kim RB
Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
[TBL] [Abstract][Full Text] [Related]
7. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
Abdullahi W; Davis TP; Ronaldson PT
AAPS J; 2017 Jul; 19(4):931-939. PubMed ID: 28447295
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier].
Ohtsuki S; Hori S; Terasaki T
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):55-64. PubMed ID: 12843573
[TBL] [Abstract][Full Text] [Related]
9. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and Ex Vivo Model Systems to Measure ABC Transporter Activity at the Blood-Brain Barrier.
de Wit NM; Kooij G; de Vries HE
Curr Pharm Des; 2016; 22(38):5768-5773. PubMed ID: 27514708
[TBL] [Abstract][Full Text] [Related]
11. ABC transporters and drug efflux at the blood-brain barrier.
Shen S; Zhang W
Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of drug transporters.
Franke RM; Gardner ER; Sparreboom A
Curr Pharm Des; 2010; 16(2):220-30. PubMed ID: 19835554
[TBL] [Abstract][Full Text] [Related]
13. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
Liu X
Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
[TBL] [Abstract][Full Text] [Related]
14. Transporter-Mediated Drug-Drug Interactions and Their Significance.
Liu X
Adv Exp Med Biol; 2019; 1141():241-291. PubMed ID: 31571167
[TBL] [Abstract][Full Text] [Related]
15. Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.
Tournier N; Declèves X; Saubaméa B; Scherrmann JM; Cisternino S
Curr Pharm Des; 2011; 17(26):2829-42. PubMed ID: 21827411
[TBL] [Abstract][Full Text] [Related]
16. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.
Schinkel AH; Jonker JW
Adv Drug Deliv Rev; 2003 Jan; 55(1):3-29. PubMed ID: 12535572
[TBL] [Abstract][Full Text] [Related]
17. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
Ohtsuki S; Terasaki T
Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
[TBL] [Abstract][Full Text] [Related]
18. Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.
Koo SH; Lo YL; Yee JY; Lee EJ
Expert Opin Drug Metab Toxicol; 2015; 11(12):1821-37. PubMed ID: 26489003
[TBL] [Abstract][Full Text] [Related]
19. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.
Miller DS
Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266
[TBL] [Abstract][Full Text] [Related]
20. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]